Immunis is a Finalist for the High Tech Award for “Best Emerging Technology Company”

IRVINE, Calif.–(BUSINESS WIRE)– #ClinicalTrials–Immunis, Inc., a private biotech and a leading innovator in cellular secretome therapies for age and disease-related immune decline, is honored to be selected as a finalist for the “Best Emerging Technology Company” by the Octane High Tech Awards (HTA). The HTA awards recognize exceptional technology companies…
Click here to view original post